This trial will study whether a new medication is effective and safe for treating prurigo nodularis, a skin condition.
- Prurigo Nodularis
1 Primary · 3 Secondary · Reporting Duration: Up to Week 48
Side Effects for
4 Treatment Groups
INCB054707 Dose A
1 of 4
INCB054707 Dose B
1 of 4
INCB054707 Dose C
1 of 4
Placebo followed by INCB054707 Dose B or C
1 of 4
145 Total Participants · 4 Treatment Groups
Primary Treatment: INCB054707 · Has Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
|Investigative Site US003||50.0%|
|Investigative Site CA001||50.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||50.0%|
Frequently Asked Questions
Could you please elaborate on the risks associated with INCB054707?
"INCB054707 falls into Phase 2 of clinical trials. While there is data suggesting it is safe, none of the trials have yet shown that it is an effective medication." - Anonymous Online Contributor
How many patients are being monitored in this clinical trial?
"One hundred and forty participants who satisfy the prerequisites are needed for this experiment. Those taking part can do so from various locations, such as Investigative Site US024 in Phoenix, Arizona or Investigative Site US018 in Dallas, Texas." - Anonymous Online Contributor
In how many different countries is this trial taking place?
"28 clinical sites are enrolling patients for this trial, such as Investigative Site US024 in Phoenix, Investigative Site US018 in Dallas, and Investigative Site US005 in Austin. There are also enrolment locations." - Anonymous Online Contributor
Are new participants being sought for this experiment?
"The trial you are inquiring about is, as of now, searching for patients to participate. This information was updated as recently as November 15th, 2021 on clinicaltrials.gov. The trial was originally posted almost a year ago on November 4th, 2020." - Anonymous Online Contributor